GlassScriptPhysician profile
Richard A Mouchantat
NPI 1013937390
$6,021.61
in general payments reported to CMS, 2019-2025
20 companies · $3,146 in 2025
The $3,146 reported for 2025 was more than what 88% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $118 · 2021: $723 · 2022: $395 · 2023: $99.93 · 2024: $882 · 2025: $3,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,302 · Honoraria: $1,500 · Long Term Medical Supply Or Device Loan: $326 · Education: $0.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,301.97 |
| Honoraria | $1,500.00 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Education | $0.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bimini Technologies LLC | $1,500.00 | 2025 | |
| Mentor Worldwide LLC | $732.76 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memoryshape Breast Implant |
| Integra Lifesciences Corporation | $729.70 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Sientra, INC. | $501.30 | 2021 | |
| Abbvie INC. | $348.84 | 2023-2025 | |
| Allergan, INC. | $309.74 | 2019-2022 | |
| Innovation Technologies INC | $300.52 | 2022-2025 | Irrisept |
| Davol INC. | $243.81 | 2025 | Surgiphor, Phasix Mesh |
| Tela Bio, INC. | $229.34 | 2024 | Ovitex 2s |
| Rti Surgical, INC | $221.20 | 2022 | |
| Becton, Dickinson and Company | $214.79 | 2024-2025 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $195.55 | 2024 | |
| Tepha INC | $171.08 | 2019 | |
| W. L. Gore & Associates, INC. | $133.22 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Motiva USA, LLC | $56.02 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $54.27 | 2025 | |
| Bone Support INC. | $26.60 | 2024 | Cerament G, Ceramentbone Void Filler |
| Biotissue Holdings INC. | $18.13 | 2025 | |
| Smith+Nephew, INC. | $17.76 | 2024 | Renasys Touch, Pico |
| Coopersurgical, INC. | $16.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mouchantat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.